Peer review reports
From: NR1D1 suppressed the growth of ovarian cancer by abrogating the JAK/STAT3 signaling pathway
Original Submission | ||
---|---|---|
17 Jan 2021 | Submitted | Original manuscript |
15 Mar 2021 | Reviewed | Reviewer Report |
17 Mar 2021 | Reviewed | Reviewer Report |
23 Mar 2021 | Reviewed | Reviewer Report |
8 May 2021 | Author responded | Author comments - Huailin Wang |
Resubmission - Version 2 | ||
8 May 2021 | Submitted | Manuscript version 2 |
6 Jun 2021 | Reviewed | Reviewer Report |
7 Jun 2021 | Reviewed | Reviewer Report |
8 Jun 2021 | Reviewed | Reviewer Report |
15 Jun 2021 | Author responded | Author comments - Huailin Wang |
Resubmission - Version 3 | ||
15 Jun 2021 | Submitted | Manuscript version 3 |
28 Jun 2021 | Author responded | Author comments - Huailin Wang |
Resubmission - Version 4 | ||
28 Jun 2021 | Submitted | Manuscript version 4 |
Publishing | ||
6 Jul 2021 | Editorially accepted | |
30 Jul 2021 | Article published | 10.1186/s12885-021-08597-8 |